Bolt Biotherapeutics(BOLT)
$5.80-0.28 (-4.61%)
BOLT
Bolt Biotherapeutics earnings date
$5.80
At close:-0.28 (-4.61%)
Want to see BOLT full AI Analyst Report?
Bolt Biotherapeutics (BOLT) Q2 2026 Earnings Report
255 Followers
BOLT Q2 2026 EPS Results
- Actual EPS
- -$4.57
- Consensus EPS
- -$3.39
- Beat/Miss
- Missed by -$1.18
- One Year Ago EPS
- -$4.46
BOLT Q2 2026 Revenue Results
- Actual Revenue
- $5,000
- Expected Revenue
- $500.00K
- Beat/Miss
- Missed by -$495.00K
- YoY Revenue Growth
- -99.72%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/11/2026
- Time
- After Close
- Conference Call
- Tuesday, August 11, 2026
BOLT Upcoming Earnings
Bolt Biotherapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
BOLT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -3.85- | -3.84 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -3.69-2.25 | -3.72 | 39.52% (+1.47) | |
| Aug 11, 2026 | 2026 (Q2) | -3.39-4.57 | -4.46 | -2.47% (-0.11) | |
| May 12, 2026 | 2026 (Q1) | -2.85-4.31 | -5.8 | 25.69% (+1.49) | |
| Mar 12, 2026 | 2025 (Q4) | -6.11-3.84 | -8.4 | 54.29% (+4.56) | |
| Nov 12, 2025 | 2025 (Q3) | -5.68-3.72 | -8 | 53.50% (+4.28) | |
| Aug 14, 2025 | 2025 (Q2) | -6.30-4.46 | -11.2 | 60.18% (+6.74) | |
| May 12, 2025 | 2025 (Q1) | -7.10-5.80 | -5.6 | -3.57% (-0.20) | |
| Mar 24, 2025 | 2024 (Q4) | -7.60-8.40 | -9.4 | 10.64% (+1.00) | |
| Nov 12, 2024 | 2024 (Q3) | -6.80-8.00 | -8.6 | 6.98% (+0.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

